The odds of the three nons when an aptly prescribed medicine isn't working: non-compliance, non-absorption, non-response.
作者信息
Urquhart John
机构信息
Pharmaco-epidemiology Group, Maastricht University, Maastricht NL, AARDEX Ltd, Zug, Switzerland.
出版信息
Br J Clin Pharmacol. 2002 Aug;54(2):212-20. doi: 10.1046/j.1365-2125.2002.01629.x.
Abstract
摘要
相似文献
1
The odds of the three nons when an aptly prescribed medicine isn't working: non-compliance, non-absorption, non-response.
Br J Clin Pharmacol. 2002 Aug;54(2):212-20. doi: 10.1046/j.1365-2125.2002.01629.x.
2
Prescription drugs and the elderly. Strategies for effective drug prescribing and use.
Mobius. 1984 Oct;4(4):145-55. doi: 10.1002/chp.4760040434.
3
Drug-taking compliance as an innovation-decision process.
Health Serv Res. 1978 Winter;13(4):439-41.
4
Knocking off our white hats--again.
Pa Med. 1994 Jan;97(1):10.
5
Enhancing concordance with prescribed medication in older people.
Nurs Older People. 2004 Mar;16(1):14-7. doi: 10.7748/nop2004.03.16.1.14.c2288.
6
Medication for the elderly. Recommendations of RCP working party.
Lancet. 1984 Feb 4;1(8371):271-2.
7
What's in a name? Medication terms: what they mean and when to use them.
Br J Ophthalmol. 2007 Nov;91(11):1422-4. doi: 10.1136/bjo.2007.118117.
8
Patient adherence to drug regimens.
Nurs Times. 2006;102(26):52.
9
10
[Analysis of drug prescriptions--the possibility of determining the justification of prescriptions and patient compliance].
Z Arztl Fortbild (Jena). 1981 Sep 15;75(18):854-5.
引用本文的文献
1
Latent Profile Analysis of Medication Beliefs in Patients with Type 2 Diabetes in the Hospital-Home Transition and Comparison with Medication Adherence.
Patient Prefer Adherence. 2024 Apr 16;18:839-853. doi: 10.2147/PPA.S450107. eCollection 2024.
2
How drug onset rate and duration of action affect drug forgiveness.
J Pharmacokinet Pharmacodyn. 2024 Jun;51(3):213-226. doi: 10.1007/s10928-023-09897-1. Epub 2024 Jan 10.
3
Initial medication adherence in newly diagnosed glaucoma patients: three adherence measures.
Int J Ophthalmol. 2023 Apr 18;16(4):630-637. doi: 10.18240/ijo.2023.04.18. eCollection 2023.
4
Lifestyle modification and medication use among diabetes mellitus patients attending Jimma University Medical Center, Jimma zone, south west Ethiopia.
Sci Rep. 2023 Mar 27;13(1):4956. doi: 10.1038/s41598-023-32145-y.
5
German Mobile Apps for Patients With Psoriasis: Systematic Search and Evaluation.
JMIR Mhealth Uhealth. 2022 May 26;10(5):e34017. doi: 10.2196/34017.
6
Impact of adherence goal awareness intervention on PDC in various settings: Does awareness help modify medication-taking behavior?
Explor Res Clin Soc Pharm. 2021 Sep 23;4:100072. doi: 10.1016/j.rcsop.2021.100072. eCollection 2021 Dec.
7
Acceleration in Germination Plays a Central Role on Seedling Vigor in Post-Germination.
Plants (Basel). 2021 Oct 11;10(10):2151. doi: 10.3390/plants10102151.
8
Water Dynamics on Germinating Diaspores: Physiological Perspectives from Biophysical Measurements.
Plant Phenomics. 2020 Dec 6;2020:5196176. doi: 10.34133/2020/5196176. eCollection 2020.
9
Evaluation of risk factors and drug adherence in the occurrence of stroke in patients with atrial fibrillation.
Pharm Pract (Granada). 2020 Apr-Jun;18(2):1860. doi: 10.18549/PharmPract.2020.2.1860. Epub 2020 Jun 3.
10
Examining Parental Medication Adherence as a Predictor of Child Medication Adherence in Pediatric Anxiety Disorders.
Med Care. 2018 Jun;56(6):510-519. doi: 10.1097/MLR.0000000000000911.
本文引用的文献
1
Patient co-operation and the sensitivity of clinical trials.
J Chronic Dis. 1962 Nov;15:1025-36. doi: 10.1016/0021-9681(62)90123-6.
2
Benefits of electronic pillboxes in evaluating treatment compliance of patients with mild to moderate hypertension.
J Hypertens. 1996 Jan;14(1):137-44.
3
Demonstrating effectiveness in a post-placebo era.
Clin Pharmacol Ther. 2001 Aug;70(2):115-20. doi: 10.1067/mcp.2001.117285.
4
Why Objective Monitoring of Compliance is Important in the Management of Hypertension.
J Clin Hypertens (Greenwich). 2000 Jul;2(4):258-262.
5
Improving on a coin toss to predict patient adherence to medications.
Ann Intern Med. 2001 May 15;134(10):1004-6. doi: 10.7326/0003-4819-134-10-200105150-00015.
6
Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions.
J Hypertens. 2001 Feb;19(2):335-41. doi: 10.1097/00004872-200102000-00022.
7
Pharmacodynamics of variable patient compliance: implications for pharmaceutical value.
Adv Drug Deliv Rev. 1998 Sep 7;33(3):207-219. doi: 10.1016/s0169-409x(98)00029-5.
8
Electronic pill-boxes in the evaluation of antihypertensive treatment compliance: comparison of once daily versus twice daily regimen.
Am J Hypertens. 2000 Feb;13(2):184-90. doi: 10.1016/s0895-7061(99)00175-2.
9
A design for testing interventions to improve adherence within a hypertension clinical trial.
Control Clin Trials. 2000 Feb;21(1):62-72. doi: 10.1016/s0197-2456(99)00049-5.
10
A comparison of enalapril 20 mg once daily versus 10 mg twice daily in terms of blood pressure lowering and patient compliance.
J Hypertens. 1999 Nov;17(11):1627-31. doi: 10.1097/00004872-199917110-00017.
Zotero 插件